6.
Bont L, Heijnen C, Kavelaars A, van Aalderen W, Brus F, Draaisma J
. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J. 1999; 14(1):144-9.
DOI: 10.1034/j.1399-3003.1999.14a24.x.
View
7.
Martin-Vicente M, Resino S, Martinez I
. Early innate immune response triggered by the human respiratory syncytial virus and its regulation by ubiquitination/deubiquitination processes. J Biomed Sci. 2022; 29(1):11.
PMC: 8841119.
DOI: 10.1186/s12929-022-00793-3.
View
8.
Qi E, Courcoubetis G, Liljegren E, Herrera E, Nguyen N, Nadri M
. Investigation of liquid biopsy analytes in peripheral blood of individuals after SARS-CoV-2 infection. EBioMedicine. 2023; 90:104519.
PMC: 10008671.
DOI: 10.1016/j.ebiom.2023.104519.
View
9.
Openshaw P, Chiu C, Culley F, Johansson C
. Protective and Harmful Immunity to RSV Infection. Annu Rev Immunol. 2017; 35:501-532.
DOI: 10.1146/annurev-immunol-051116-052206.
View
10.
Bohmwald K, Galvez N, Canedo-Marroquin G, Pizarro-Ortega M, Andrade-Parra C, Gomez-Santander F
. Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection. Front Immunol. 2019; 10:452.
PMC: 6431622.
DOI: 10.3389/fimmu.2019.00452.
View
11.
SUNG R, Yin J, Oppenheimer S, Tam J, Lau J
. Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a. Arch Dis Child. 1993; 69(4):440-2.
PMC: 1029552.
DOI: 10.1136/adc.69.4.440.
View
12.
Gatt D, Martin I, AlFouzan R, Moraes T
. Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV). Pathogens. 2023; 12(2).
PMC: 9961958.
DOI: 10.3390/pathogens12020154.
View
13.
Marguet C, Bocquel N, Benichou J, Basuyau J, Hellot M, Couderc L
. Neutrophil but not eosinophil inflammation is related to the severity of a first acute epidemic bronchiolitis in young infants. Pediatr Allergy Immunol. 2007; 19(2):157-65.
DOI: 10.1111/j.1399-3038.2007.00600.x.
View
14.
Crawford A, Angelosanto J, Nadwodny K, Blackburn S, Wherry E
. A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection. PLoS Pathog. 2011; 7(7):e1002098.
PMC: 3141034.
DOI: 10.1371/journal.ppat.1002098.
View
15.
Gonzalez-Sanz R, Mata M, Bermejo-Martin J, Alvarez A, Cortijo J, Melero J
. ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation. J Virol. 2016; 90(7):3428-38.
PMC: 4794669.
DOI: 10.1128/JVI.02695-15.
View
16.
Spann K, Baturcam E, Schagen J, Jones C, Straub C, Preston F
. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy. Thorax. 2014; 69(10):918-25.
PMC: 4174127.
DOI: 10.1136/thoraxjnl-2013-204908.
View
17.
Jin X, Wang Y, Xu J, Li Y, Cheng F, Luo Y
. Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19. Mol Genet Genomics. 2023; 298(4):823-836.
PMC: 10104435.
DOI: 10.1007/s00438-023-02014-4.
View
18.
Kampmann B, Madhi S, Munjal I, Simoes E, Pahud B, Llapur C
. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023; 388(16):1451-1464.
DOI: 10.1056/NEJMoa2216480.
View
19.
Walsh E
. Respiratory Syncytial Virus Infection: An Illness for All Ages. Clin Chest Med. 2017; 38(1):29-36.
PMC: 5844562.
DOI: 10.1016/j.ccm.2016.11.010.
View
20.
Piedra F, Mei M, Avadhanula V, Mehta R, Aideyan L, Garofalo R
. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis. PLoS One. 2017; 12(3):e0172953.
PMC: 5340370.
DOI: 10.1371/journal.pone.0172953.
View